IE48395B1 - Octahydro pyrazolo(3,4-g)quinolines - Google Patents

Octahydro pyrazolo(3,4-g)quinolines

Info

Publication number
IE48395B1
IE48395B1 IE2794/83A IE279479A IE48395B1 IE 48395 B1 IE48395 B1 IE 48395B1 IE 2794/83 A IE2794/83 A IE 2794/83A IE 279479 A IE279479 A IE 279479A IE 48395 B1 IE48395 B1 IE 48395B1
Authority
IE
Ireland
Prior art keywords
mixture
trans
quinoline
pyrazolo
chloroform
Prior art date
Application number
IE2794/83A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/031,641 external-priority patent/US4198415A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IE48395B1 publication Critical patent/IE48395B1/en

Links

Description

This invention relates to compounds useful in the preparation of octahydropyrazolo[3,4-q]quinolines of the Ia lb wherein R is (C-C ) alkyl or allyl? 1 J R is H or CH2X wherein X is OCH^, SCH^, CN, SC^CH^ or CONH^; and pharmaceutically-acceptable acid addition salts thereof.
The compounds of formulae Ia and lb above are prepaformula Villa wherein - 3 R is H, CN, (C.-C)alkyl or allyl; R1 is H, -COOH, -C-O(C1~C2)alkyl, -C-O-substituted(C .j-C2) a Iky lphenyl ; with hydrazine hydrate; followed by, when R is CN, reacting with zinc and acetic acid to form the compounds where R is H; followed by, when R is H, reacting with an alkyl or allyl halide or reductive alkylation with an appropriate aldehyde and metal hydride to obtain the compounds of formulae Ia and lb where R is (C^-C.^)alkyl or allyl; followed by, when R3 is other than H, reacting with a metal hydride to obtain the intermediate compounds of formulae Ia and lb wherein R^ is CH^OH, followed by reacting with a nucleophilic reagent to obtain the intermediate compounds of formulae la and lb wherein R^ is CH2Y where Y is Cl, Br, OSC>2phenyl, O-tosyl, or OSC>2 (C^-C3) alkyl, followed by reacting with sodium methylate, methyl mercaptan sodium salt, sodium cyanide, sodium methanesulfinate, to obtain the compounds of formulae la and lb wherein is CUfX where X is CN, SCH3, SO2CH3, or OCH ,· and optionally followed by reacting the compounds of formulae Ia and lb where R^ is CH„CN with hydration to obtain 2 1 the compounds of formulae la and lb where R is CHjCONHj.
The compounds of formulae la and lb, together with their pharmaceutically-acceptable salts thereof, are useful chiefly as dopamine agonists.
This invention provides compounds of the following general formulae - 4 4833a R R Ic Id wherein R is H, CN, Cj-C alkyl or benzyl,R1 is H, -COOH, -COO(C-C)alkyl, or GH.X wherein X I «3 is Cl, Br, I, OH, OSO2~(Cj-C3)alkyl, OSO2tolyl, or OS 0., pheny 1,with the proviso that when R is C-C alkyl, then R can not be H; and the salts thereof.
All salts of these compounds are useful in purification or synthetic procedures.
In the above formulas, the term (C^-C^alkyl includes methyl and ethyl and (C^-C^)alkyl includes also npropyl and isopropyl. The term tolyl includes p, m and otolyl.
The pharmaceutically-acceptable acid addition salts of formulae Ia-Id include salts derived from inorganic acids such as: hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid, hydrobromic acid, hydriodic acid, nitrous acid, phosphorous acid and the like, as well as salts derived from nontoxic organic acids such as aliphatic mono and dicarboxylic acids, phenyl-substituted alkanoic acids, hydroxy alkanoic and alkandioic acids, aromatic acids, aliphatic and aromatic sulfonic acids. Such pharinaceutically-acceptable salts thus include sulfate, pyrosulfate, bisulfate, sulfite, bisulfite, nitrate, phosphate, monohydrogenphosphate, di48395 - 5 hydrogenphosphate, metaphosphate, pyrophosphate, chloride, bromide, iodide, fluoride, acetate, propionate, decanoate, caprylate, acrylate, formate, isobutyrate, caprate, heptanoate, propiolate, oxalate, malonate, succinate, suberate, sebacate, fumarate, maleate, mandelate, butyne-1,4-dioate, hexyne1,6-dioate, benzoate, chlorobenzoate, methylbenzoate, dinitrobenzoate, hydroxybenzoate, methoxybenzoate, phthalate, terephthalate, benzenesulfonate, toluenesulfonate, chlorobenzenesulfonate, xylenesulfonate, phenylacetate, phenylpropionate, phenyIbutyrate, citrate, lactate, β-hydroxybutyrate, glycollate, malate, tartrate, methanesulfonate, propanesulfonate, naphthalene-l-sulfonate, naphthalene-2-sulfonate and the like salts.
Compounds according to Ic above are named systematically as 4, 4a, 5, 6, 7, 8, 8a, 9-octahydro-UI-pyrazolo[3,4-g]quinolines and those according to Id as 4, 4a, 5, 6, 7, 8, 8a, 9-octahydro-2H-pyrazolo[3,4-g] quinolines. These two structures represent a tautomeric pair and the tautomers represented by the structures are in dynamic equilibrium. In addition, compounds represented by formulas Io and Id above when is H have two chiral centers, the ring junction carbons at 8a and 4a. Thus, the compounds can occur as two racemates, ordinarily denominated as the trans-dl racemate and the cis-dl racemate.
It is believed, however, according to the best evidence from 13 C NMR spectral data, that the cyanoborohydride reduction process which introduces hydrogens at the quinoline bridgehead, a step in the synthetic procedure used to prepare the compounds of formulae Ic and Id yields a trans-fused decahydroquinoline. While the arguments for the trans configuration 13 based upon C NMR spectral data are compelling, an X-ray crystallographic investigation has also been carried out on a nicely crystalline enaminoketone in the decahydroquinoline series (VIII, R=CH3). This X-ray analysis indicates clearly that the ring junction in the quinoline moiety is trans.
Further operations on the decahydroquinoline molecule to condense a pyrazole ring thereon do not alter the configuration of the bridge-head hydrogens. Thus, only the trans racemate is prepared by the synthetic procedures to be disclosed hereinafter and the compounds of formulae la and lb are preferably represented as the trans-dl stereoisomers. The two trans stereoisomers of the 2H tautomer can be represented as follows: R Ila Ila and lib represent a racemic pair, can be drawn for the IH tautomer.
R lib A similar racemic pair lie lid lie and lid also represent a racemic pair.
Resolution of these racemates into their optical antipodes can be accomplished by procedures known to those skilled in the art, and the individual trans-d and trans-1 isomers are included within the scope of this invention. - 7 In addition, where is other than H, a third chiral center is introduced at C-7. However, it is presently believed that the configuration of the C-7 group is chiefly beta relative to an alpha 8a hydrogen as in Ila. In the mirror image, lib, R^ is alpha with respect to 8a being beta. Thus, the trans-dl 7-substituted octahydropyrazolo[3,4-g]quinolines of formulae Ic and Id are provided substantially as a single racemate or diastereoisomeric pair.
An equilibrium mixture of the two tautomers is always present. The 2H tautomer apparently predominates in several of the tautomeric mixtures. In addition, the orientation of substituents is not given, nor is the configuration of the hydrogens at 4a and 8a, but it is understood that the hydrogens are trans to one another and that the 7 substituent is trans to the 8a hydrogen; i.e., when the 8a hydrogen is alpha, the 7-substituent is beta and when the 8a hydrogen is beta, the 7 substituent is oriented in the alpha configuration.
The compounds of formulae Ic and Id in which R1 is H are prepared according to the following procedure as outlined in Reaction Scheme I. In the Reaction Scheme, only one stereoisomer of the racemic pair, the 4ap, 8aa isomer, has been drawn for convenience but it should be remembered that each decahydroquinoline and each octahydropyrazolo[3,4-g]quinoline exists as a racemate.
Reaction Scheme I pyrrolidine acrylamide acid catalyst I —co —z Z— CO— III H RX I NaH Z HO CO I // — // IV HO VI Ο ι HN.
IX R HCl NaCNBH CrO, H2S°4 HH2NH2.H2O VII H o zv=y (ch3)2NCH(OZ'·)2 ( ch3)2nch H VIII In the above reaction scheme, Z-CO is an acyl protecting group in which Z is (C^-^)alkyl, (C2~C3)alkenyl, (Cj-C )alkynyl, (C--C )cycloalkyl, phenyl or substituted phenyl b b wherein the substituting group can be methyl, methoxy, chloro and the like at any position of the phenyl ring. Illustratively, Z-CO can be acetyl, propionyl, butyryl, propiolyl, acrylyl, benzoyl, p-toluyl, o-chlorobenzoyl, m-methoxybenzoyl, and so on.
Z” is defined hereinbelow in the discussion of Reaction Scheme II. In accordance with Reaction Scheme I, 4acyloxycyclohexanone prepared by the procedure of E.R.H.
Jones and F. Sondheimer, J, Chem. Soc.. 615, (1949) for 4benzoyloxycyclohexanone, is reacted with pyrrolidine in the presence of an acid catalyst to yield the pyrrolidine enamine. This enamine is in turn reacted with acrylamide to produce a mixture of dl-6-acyloxy-3,4,5,6,7,8-hexahydro-2(lH)quinolinone and dl-6-acyloxy-3,4,4a,5,6,7-hexahydro-2(1H)quinolinone represented by formula III, the dotted lines indicating the alternative positions of the double bond.
Next, the acidic nitrogen (acidic since it is alpha to a carbonyl group) is alkylated with an alkyl halide RX wherein R has the same meaning as hereinabove and X is a halogen such as Cl, Br or I, in the presence of sodium hydride to yield a mixture of dl-l-(C.-C_) alkyl (or allyl or benzyl)X J β 6-acyloxy-3,4,5,6,7,8-hexahydro-2(lH) quinolinone and its Δ isomer (IV). Reduction of this amide with lithium aluminium hydride or other suitable organometallic reducing agent yields a mixture of dl-1-(C.-C )alkyl-(or allyl or benzyl)-63 θ hydroxy-l,2,3,4,5,6,7,8-octahydroquinoline and its Δ isomer. In this reaction mixture, conditions are encountered which also serve to hydrogenolyze the acyloxy group to a hydroxyl group at C-6. This dl-1-(C^-C^Jalkyl (or allyl or benzyl)-6- 10 hydroxyoctahydroquinoline is next converted to an ammonium salt by treatment with hydrochloric acid, and the ammonium salt is then reduced with sodium cyanoborohydride to yield trans-dl-1-(C^-C^)-alkyl (or allyl or benzyl)-6-hydroxydeca5 hydroquinoline (VI). Next, the trans-dl-1-(C^-C^ alkyl, allyl, or benzyl)-6-hydroxydecahydroquinoline (VI, is oxidized using, preferably, chromium trioxide in acetic acid, to yield the corresponding 6-oxo compound (VII).
This 6-oxo compound (VII) is reacted with dimethylformamide dimethylacetal to yield a 7-dimethylaminomethylene-6-oxoderivative (VIII). Reaction of this derivative with hydrazine hydrate yields a tautomeric mixture of a tricyclic derivative, predominately trans-dl-S-ZIC^-C^ alkyl, allyl or benzyl)_7-4,4a,5,6,7,8,8a,9-octahydro-2H15 pyrazolo/’3,4-q/’quinoline (IX) and its IH tautomer (IXa) in smaller amount.
The compounds of formulae Ia and lb wherein R is alkyl, can also be prepared from compounds in which R is benzyl. In this procedure, the benzyl group is removed by reductive cleavage or by treatment with cyanogen bromide to yield, eventually, a compound according to IX or IXa in which R is H progressing thru an intermediate when cyanogen bromide is used in which R is CN. This debenzylated compound can then be alkylated with a lower alkyl halide, or alternatively it may be reductively alkylated using acetaldehyde, acrolein or propionaldehyde in each instance with a metal hydride, such as sodium cyanoborohydride, to yield the desired N-alkyl derivative.
The usual conditions for removing and N-benzyl group are hydrogen with a palladium-on-carbon catalyst or reaction with cyanogenbromide followed by reductive (Zn and acetic acid) cleavage of the N-cyano compound.
In the above reaction scheme, it is apparent from an inspection of the dl-trans-1(substituted)-6-ketodecahydro35 quinoline (VII) that reaction with dimethylformamide dimethyl48395 acetal could take place at either C-5 or C-7 since both these carbons are alpha to the ketone group and thus available for reaction. The same X-ray crystallographic analysis of the enamine (VIII) discussed above clearly indicated that reaction had taken place at C-7 rather than C-5. Hence, the final tricyclic compounds, IX and IXa, are the linear pyrazolo[3,4-g] quinolines rather than the angular tricyclic compounds (which would be named as 4,4a,5,6,7,8,8a,9-octahydro-lHpyrazolo[2,3-i] quinolines.
The compounds of this invention in which R1 is other than H are prepared according to a slightly different procedure illustrated generally in Reaction Scheme II. As in Reaction Scheme I the procedure is exemplified with only (referring to the stereochemistry of the bridge-head) a single stereoisomer, the 4ap, 8aa isomer. - 12 Reaction Scheme II CO I o RNHCH =C-COOZ' 2 I COOZ’ O-CO-Z CH2Hal acid 5H4 XV R 46395 wherein Z and Z'1 have the same significance as in Reaction Scheme I, Hal is chloro or bromo and Z' is part of a readily hydrolyzable group Z’O-CO such as (C^-C^alkyl, phenyl substituted- (c^-CjJalkyl, illustratively benzyl, phenethyl, pmethoxybenzyl, methyl, or ethyl.
In accordance with the Reaction Scheme II, a 4acyloxycyclohexanone is reacted with an a-halomethylacrylate ester, for illustrative purposes, the ethyl ester and an amine, RNH^· wherein R is alkyl, allyl or benzyl. The product of this reaction is a mixture of dl-l-substituted-3ethoxycarbonyl-6-acyloxy-l,2,3,4,5,6,7,8-octahydroquinoline and dl-l-substituted-3-ethoxycarbonyl-6-acyloxy-l,2,3,4,4a, ,6,7-octahydroquinoline represented by X in which the dotted line indicates the alternate positions of the double bonds.
The hydrochloride salts of these isomers were prepared and the resulting mixture reduced with sodium cyanoborohydride to yield trans-dl-l-substituted-3-ethdxycarbony1-6-acyloxydecahydroquinoline (XI). Hydrolysis of this diester to yie Id a 6-hydroxy-3-carboxylic acid followed by reesterification of the carboxylic acid group with ethanol or other suitable alcohol in the presence of acid yields trans-dl-1-substituted3-ethoxycarbonyl-6-hydroxydecahydroquinoline (XII). Oxidation of the hydroxy group with Sarett's Reagent (pyridine hydrochloride and chromium trioxide) produces the corresponding 6oxo-compound (XIII). Treatment of this 6-oxo derivative with a dimethylformamide acetal, preferably dimethylformamide dimethylacetal, results in a reaction at C-7 (adjacent to the keto group) to give, trans-dl-l-substituted-3-ethoxycarbonyl-6-oxo-7-(dimethylaminomethylene)decahydroquinoline (XIV). Reaction of this derivative as in Reaction Scheme I above with hydrazine hydrate results in a mixture comprising trans-dl-5-substitu4 8 3 9 5 - 14 ted-7-ethoxycarbonyl-4,4a,5,6,7,8,8a,9-octahydro-lH-pyrazolo[3,4-g]quinoline and its 2H tautomer (represented by XV as a single stereoisomer). The compound can be isolated and purified as the free base or as the dihydroehloride salt, prepared according to conventional procedures.
Acetals of dimethylformamide useful in producing compound VIII in Reaction Scheme I and compound XIV in Reaction Scheme II have the general formula (CH3)^N-CH-(OZ'1)% in which Z'' is (C.-C )-alkyl, (C -C )cycloalkyl, (C -C ) alkenyl, ο o J 4 (c^-cyalkynyl and the like. We prefer to employ one of the commercially available acetals of dimethylformamide? i.e.; the dimethyl, diethyl, diisopropyl, dibutyl, dicyclohexyl, dipropyl or dineopentyl acetals.
In formula XV above, R is (C^-C^)alkyl, allyl or 15 benzyl. The octahydropyrazolo]3,4-g] quinoline of Formula XV represents a single tautomer, the 2H tautomer, and only one diastereoisomer. The mirror image of XV is also prepared and is included within the scope of this invention. We believe based upon analogy with the D-ergolines that the diastereo20 isomer XV is the isomer having dopamine agonist activity.
The trans-dl racemate, which contains XV and its mirror image, is of course useful as a dopamine agonist, even though most of the desired activity resides in one of its component stereoisomers.
Compounds according to XV above in which R is ethyl, or n-propyl can be prepared by two different procedures.
First, the amine, RNH^, used in preparing X can be ethyl or n-propyl, thus introducing the group directly. Alternatively a compound according to XV in which R is methyl or benzyl can be transformed into a compound in which R is H by removing the methyl or benzyl group by reaction with cyanogen bromide. The intermediate 5-cyano (R is CN) derivative can be reduc48395 - 15 tively cleaved (zinc plus acetic acid) to yield a compound in which R is H. In addition, the benzyl group can be removed by hydrogenation with palladium-on-carbon to yield those intermediates in which R=H, Alkylation of the secondary amine can be accomplished by reaction with an alkyl halide— RC1, RBr or RI. Alternatively, the secondary amine group can be reacted with an aldehyde, such as acetaldehyde, acrolein, or propionaldehyde under reducing conditions with a metal hydride, (e.g. NaBH^CN) to yield an N-ethyl or N-npropyl derivative.
This invention is further illustrated by the following specific examples.
Example 1 Preparation of trans-dl-5-Cyano-4,4a,5,6,7,8,8a,9-octahydro-lH (and 2H)-pyra2olo[3,4-g] quinoline A reaction mixture was prepared from 65 g. of 4benzoyloxycyclohexanone, 38 ml. of pyrrolidine, a few crystals of p-toluenesulfonic acid monohydrate, and 1000 ml. of benzene. The reaction mixture was heated to refluxing temperature under a nitrogen atmosphere for one hour in an apparatus equipped with a Dean-Stark water trap. The reaction mixture was then cooled and the volatile constituents removed by evaporation in vacuo. The residue, comprising the pyrrolidine enamine of 4-benzoyloxycyclohexanone formed in the above reaction, was dissolved without further purification in 1000 ml. of dioxane. 64 g. of acrylamide were added. This new reaction mixture was heated under a nitrogen atmosphere at reflux temperature for two days after which time it was cooled and the volatile constituents removed by evaporation in vacuo.
The reaction mixture was diluted with ethyl acetate and the ethyl acetate layer separated, washed first with water and then with saturated aqueous sodium chloride. The ethyl - 16 48395 acetate layer was dried and the volatile constituents removed by evaporation in vacuo. The resulting residue, comprising a mixture of 2-oxo-6-benzoyloxy-3,4,5,6,7,8-hexahydroquinoline and 2-oxo-6-benzoyloxy-3,4,4a,5,6,7-hexahydroquinoline formed in the above reaction, was dissolved in chloroform and the chloroform solution chromatographed over florisil. Chloroform containing increasing amounts of ethanol (0 to 2 percent) was used as the eluant. Fractions found to contain 2-oxo-6-benzoyloxy-3,4,5,6,7,8-hexahydroquinoline and its Δ ' isomer by thin-layer chromatography were combined and the solvent removed therefrom in vacuo. The resulting residue was crystallized by triturating with hexane to yield a crystalline mixture of 6-benzoyloxy-3,4,5,6,7,8-hexahydro-lH-quinolin2-one and the corresponding 3,4,4a,5,6,7-hexahydro derivative.
The mixture melted in the range 13O-15O°C. after recrystallization from an ether-hexane solvent mixture.
Analysis:Calculated: C, 70.83; H, 6.32; N, 5.16.
Found: C, 71.05; H, 6.19; N, 5.33.
NMR of the product isolated above indicated that the mixture contained about 60 percent of 6-benzoyloxy-3,4,5,6,7,8hexahydro-lH-quinolin-2-one and 40 percent of the 3,4,4a,5,6,7hexahydro isomer.
A mixture of 2-oxo-6-benzoyloxy-3,4,5,6,7,8-hexa8 (8a) hydroquinoline and its Δ isomer obtained from 65 g. of 4-benzoyloxycyclohexanone as above without further purification was dissolved in a mixture of 300 ml. of tetrahydrofuran (THF) and 300 ml. of dimethylformamide. 14 g. of sodium hydride were added, thus forming the sodium salt of the quinoline.
This mixture was stirred at ambient temperature for about 20 minutes under a nitrogen atmosphere after whioh time 55 g. of benzyl bromide in 75 ml. of THF were slowly added over a 10 minute period. The reaction mixture was stirred for an 8 3.9 5 - 17 additional hour in the range 32-45°C. and was then diluted with water. The aqueous mixture was extracted with ethyl acetate. The ethyl acetate extract was separated, washed with water and with saturated aqueous sodium chloride, and then dried. Evaporation of the ethyl acetate yielded a mixture of l-benzyl-2-oxo-6-benzoyloxy-3,4,5,6,7,8-hexahydroquinoline and l-benzyl-2-oxo-6-benzoyloxy-3,4,4a,5,6,7-hexahydroquinoline; yield = lo6 g. 106 g. of the above mixture were dissolved in 1 1. of THF and the solution cooled in an ice-water bath. 40 g. of lithium aluminumhydride were added thereto in portions. After the addition had been completed, the reaction mixture was heated to refluxing temperature under a nitrogen atmosphere for about 4 hours. The reaction mixture was then cooled and excess lithium aluminumhydride destroyed by the addition of ethyl acetate. 10 percent aqueous sodium hydroxide was added to decompose any organometallic compounds present in the mixture. At this point, the reaction mixture was diluted with water. The resulting aqueous mixture was extracted several times with chloroform. The chloroform extracts were separated and combined. The combined extracts were washed with saturated aqueous sodium chloride and then dried. Evaporation of the chloroform yielded a residue comprising a mixture of 1-benzyl6-hydroxy-l,2,3,4,5,6,7,8-octahydroquinoline and 1-benzyl6-hydroxy-l,2,3,4,4a,5,6,7-octahydroquinoline. (Both the 2-oxo group and the 6-benzoyloxy group reacted with the lithium aluminum hydride to yield an octahydroquinoline with a free alcohol at C-6). The mixture of compounds thus obtained was dissolved in ether, the ethereal solution cooled, and gaseous anhydrous hydrogen chloride passed into the solution, thus forming the hydrochloride salts of the quinoline isomers. The quinoline hydrochlorides were insoluble and were separated by decantantation of the ether. The residual salts were dissolved in 100 ml. of methanol and 400 ml. of THF. The solution - 18 was cooled and 30 g. of sodium cyanoborohydride added thereto in portions. After the addition had been completed, the cooling bath was removed and the reaction mixture stirred at ambient temperature for 1.25 hours, after which time it was poured into a mixture of IN aqueous hydrochloric acid and ice. The acidic solution was extracted with ether, and the ether extract discarded. The acidic solution was then made basic with 10 percent aqueous sodium hydroxide and the alkaline mixture extracted several times with a chloroform-iso10 propanol solvent mixture. The organic extracts were combined and the combined extracts washed with saturated aqueous sodium chloride and then dried. Evaporation of the solvent yielded trans-dl-l-benzyl-6-hydroxy-decahydroquinoline formed in the above reaction; yield = 53.6 g. Total yield in 6 steps with 73 percent based upon recovered 4-benzoyloxycyclohexanone starting material. g. of trans-dl-l-benzyl-6-hydroxydecahydroquinoline were dissolved in 1.5 1. of methylene dichloride and the solution cooled in an ice-water bath. 50 g. · of cyanogen bromide were added and the resulting mixture stirred at room temperature for 15 hours. The reaction mixture was washed successively with IN aqueuos hydrochloric acid and water, and was then dried. Evaporation of the solvent yielded a residue containing trans-dl-l-cyano-6-hydroxydecahydroquinoline formed in the above reaction. The residue was dissolved in chloroform and the chloroform solution chromatographed over 300 g. of florisil using chloroform containing increasing amounts (0-2%) of methanol as the eluant. Fractions shown by TLC to contain the desired cyano compound were combined and the solvent removed from the combined fraction by evaporation in vacuo, trans-dl-l-cyano-6-hydroxydecahydroquinoline thus prepared weighed 22.5 g. 22.5 g. of trans-dl-l-cyano-8-hydroxydecahydro4 8 3 91 - 19 quinoline were dissolved in 1200 ml. of methylene dichloride. g. of pyridine hydrochloride:chromium trioxide (Sarett's Reagent) were added. The reaction mixture was stirred at room temperature under nitrogen for about 6 hours, and was then filtered. The filtrate was concentrated in vacuo and the concentrate chromatographed over 300 g. of florisil using chloroform containing 1 percent methanol as the eluant. Fractions shown by TLC to contain trans dl-l-cyano-6-oxodecahydroquinoline formed in the above reaction were combined and the combined fractions evaporated to dryness in vacuo. Recrystallization of the resulting residue from an ether-chloroform solvent mixture yielded trans-dl-l-cyano-6-oxodeeahydroguinoline melting at 86-8°C.; yield = 18.9 g.
Analysis: Calculated: C, 67.39; H, 7.92; N, 15.72.
Found: C, 67.15; H, 7.75; N, 15.46. 17.6 g. of trans-dl-l-cyano-6-oxodecahydroquinoline were dissolved in 200 ml. of benzene to which 100 g. of the dimethylacetal of dimethylformamide had been added. The reaction mixture was heated to refluxing temperature under nitrogen for about 20 hours and was then cooled. Evaporation of the solvent in vacuo yielded a residue comprising trans-dl-1cyano-6-oxo-7-dimethylaminomethylenedecahydroquinoline formed in the above reaction. The compound was purified by chromatography over 300 g. of florisil using chloroform containing increasing amounts (0-2%) of methanol as the eluant. 10.2 g. of trans-dl-l-cyano-6-oxo-7-dimethylaminomethylenedecahydroquinoline melting at 159-163°C. were obtained. The compound was crystallized from toluene to yield crystals melting at 162-4°C.
Analysis Calculated: C, 66.92; H, 8.21; N, 18.01.
Found: C, 67.14; H, 8.16; N, 18.04. .2 g. of trans-dl-l-cyano-6-oxo-7-dimethylaminomethy lenedecahydroquinoline were dissolved in 400 ml. of - 20 methanol. 2.8 g. of 85 percent hydrazine were added and the subsequent reaction mixture stirred for about 1 day under a nitrogen atmosphere. The volatile constituents were then removed by evaporation in vacuo. The residue was dissolved in chloroform and the chloroform solution chromatographed over 150 g. of florisil using chloroform containing increasing amounts (2-5%) of methanol as the eluant. Fractions shown by TLC to contain the desired octahydropyrazoloquinoline were combined and the solvent evaporated therefrom to dryness; yield = 6.3 g. Recrystallization of the residue from ethanol yielded a mixture of trans-dl-5-cyano-4,4a, 5,6,7,8,8a,9-octahydro-2H-pyrazolo]3,4-q]quinoline and its IH tautomer melting at 193-5°C.
Analysis:Calculated: C, 65.32; H, 6.98; N, 27.70 Found: C, 65.48; H, 6.80; N, 27.64 Example 2 Preparation of trans-dl-4,4a,5,6,7,8,8a,9-Octahydro-lH (and 2H)-pyrazolo[3,4-q] quinoline A reaction mixture prepared from 860 mg of trans-dl20 5-cyano-4,4a,5,6,7,8,8a,9-octahydro-IH and 2H-pyrazolo[3,4-g]quinoline, (from Example 1), 5 g. of zinc dust, 10 ml. of water and 50 ml. of acetic acid. The mixture was heated to refluxing temperature under a nitrogen atmosphere for 18.5 hours after which time it was filtered and the filtrate poured over ice. The resulting aqueous mixture was then made basic with 14N ammonium hydroxide and the resulting alkaline aqueous layer extracted several times with a chloroform-isopropanol solvent mixture. The organic extracts were combined and the combined extracts washed with saturated aqueous sodium chloride and then dried. Evaporation of the solvent yielded a residue comprising trans-dl-4,4a,5,6,7,8,8a,9-octahydro-2Hpyrazolo]3,4-q] quinoline and the IH tautomer formed in the above reaction. The residue was dissolved in ethanol and 48305 - 21 0.70 ml. of 12N aqueous hydrochloric acid added thereto.
The mixture of trans-dl-4,4a,5,6,7,8,8a,9-octahydro-2Hpyrazolo[3,4-g] quinoline and the ΙΗ-tautomer dihydrochlorides formed as above melted at 284-7°C.; yield = 780 mg.
AnalysisjCalculated: C, 48.01; H, 6.85; N, 16.80.
Found: C, 48.07; H, 7.05; N, 16.83.
Example 3 Preparation of trans-dl-5-n-Propyl-7-ethoxyearbonyl-4,4a,5,6,7,8,8a,9-octahydro-lH (and 2H)-pyrazolo[3,4-g] quinoline A mixture of 10 ml. of n-propyl amine and 400 ml. of toluene were cooled in an ice-water bath. A solution of 16.5 g. of ethyl a-(bromomethyl)acrylate in 50 ml. of toluene was added thereto in dropwise fashion. The resulting mixture was stirred with cooling for about 25 minutes. Next, a solution of 11 g. of 4-benzoyloxycyelohexanone in 75 ml. of toluene was added in dropwise fashion. This new mixture was heated under a nitrogen atmosphere to refluxing temperature for about 23 hours. The reflux condenser was equipped with a Soxhlet extractor containing a 5A sieve to remove water.
Next the reaction mixture was cooled and the cooled mixture filtered. Evaporation of the filtrate yielded a residue comprising a mixture of l-n-propyl-3-ethoxycarbonyl-6-benzoyloxy1,2,3,4,5,6,7,8-octahydroquinoline and l-n-propyl-3-ethoxycarbonyl-6-benzoyloxy-l,2,3,4,4a,5,6,7-octahydroquinoline.
The residue was dissolved in an ether-chloroform solvent mixture and the resulting solution saturated with gaseous hydrogen chloride while maintaining the temperature in the range 0-5°C. The solvent was decanted from the crystalline hydrochloride salts thus formed. The salts were dissolved in 100 ml. of methanol. 300 ml. of THF were added and the resulting solution cooled in an ice-water bath. 15 g. of sodium cyanoborohydride were added in portions to the stirred and cooled reaction mixture. After the addition had been 8 393 - 22 completed, the reaction mixture was stirred for another 1.25 hours after which time it was diluted with aqueous sodium bicarbonate. The aqueous alkaline mixture was extracted several times with ethyl acetate. The ethyl acetate extracts were com bined and the combined extracts washed with saturated aqueous sodium chloride solution and then dried. Evaporation of the solvent yielded trans-dl-l-n-propyl-3-ethoxycarbonyl-6benzoyloxydecahydroquinoline. The compound was dissolved in a mixture of 400 ml. of methanol and 100 ml. of 2N aqueous sodium hydroxide. This mixture was stirred at ambient temperature under a nitrogen atmosphere for 64 hours after which time the volatile constituents were removed by evaporation in vacuo The resulting residue was suspended in 800 ml. of ethanol and 15 ml. of 12N agueous hydrochloric acid. The esterification mixture was heated to refluxing temperature and about 3Q0 ml. of solvent removed by distillation. 300 ml. of additional ethanol were added and the reaction mixture heated to refluxing temperature for 26 hours in an apparatus equipped with a Soxhlet trap containing a 3A sieve. The reaction mixture was cooled, diluted with aqueous sodium bicarbonate and the alkaline mixture extracted several times with chloroform. The chloroform extracts were combined and the combined extracts washed with saturated aqueous sodium chloride and then dried. Evaporation of the chloroform yielded 10.3 g. of a residue comprising trans-dl-l-n-propyl-3-ethoxycarbonyl-6-hydroxydecahydroquinoline formed in the above hydrolysis after chromatography over 150 g. of florisil using chloroform containing increasing amounts (2—10%) of methanol as the eluant.
A solution was prepared from 8.8 g. of trans-dl-1-n30 propyl-3-ethoxycarbonyl-6-hydroxydecahydroquinoline and 400 ml. of methylene dichloride. 4.1 g. of sodium acetate were' added. Next, 10.8 g. of pyridine hydrochloride:chromium trioxide were added and the resulting mixture stirred for about 22 - 23 hours. The reaction mixture was filtered and the filtrate concentrated in vacuo. The resulting concentrate was dissolved in chloroform and the chloroform solution chromatographed over 150 g. of florisil using chloroform containing increasing amounts (1-2%) of methanol as the eluant. Fractions shown by thin-layer chromatography to contain trans-dl-l-n-propyl-3ethoxycarbonyl-6-oxodecahydroquinoline formed in the above reaction were combined and the solvent removed from the combined extracts to yield 3.48 g. of the 6-oxo compound as a residue. The 6-oxo compound was dissolved in 100 ml. of toluene containing an added 25 ml. of the dimethylacetal of dimethylformamide. The resulting mixture was heated to refluxing temperature under a nitrogen atmosphere for 44 hours and was then allowed to remain at room temperature for an addi15 tional 4 days. Volatile constituents were removed by evaporation in vacuo and the residue, comprising trans-dl-l-n-propyl3-e thoxycarbony1-6-oxo-7-(dime thylaminome thylene)decahydroquinoline formed in the above reaction, was purified by chromatographing a chloroform solution of the compound over florisil using chloroform containing increasing amounts (2-5%) of methanol as the eluant. Fractions shown by TLC to contain the desired 7-dimethylaminomethylene compound were combined and the solvent evaporated therefrom in vacuo.
A solution was prepared from 2.24 g. of trans-dl-1-n25 propyl-3-ethoxycarbonyl-6-oxo-7-dimethylaminomethylene decahydroquinoline and 150 ml, of ethanol. 0.45 ml. of hydrazine hydrate were added and the resulting mixture stirred at ambient temperature for about 17 hours. The reaction mixture was evaporated to dryness in vacuo. The residue containing a mixture of trans-dl-5-n-propyl-7-ethoxycarbonyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-q] quinoline and trans-dl-5-npropyl-7-ethoxycarbony1-4,4a,5,6,7,8,8a,9-octahydro-lH-pyrazolo[3,4-g] quinoline was dissolved in chloroform and the re48 39 5 - 24 suiting solution chromatographed over 35 g. of florisil using chloroform containing 2 percent methanol as an eluant. Fractions shown to contain the desired pyrazoloquinoline by TLC were combined and the solvent evaporated therefrom in vacuo. Recrystallization from a mixture of ether and hexane yielded trans-dl-5-n-propyl-7-ethoxycarbonyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinoline and its IH tautomer melting at 125-7°C.
AnalysiszCalculated: C, 65.95; H, 8.65; N, 14.42.
Found: C, 65.75; H, 8.42; N, 14.16.
Example 4 Preparation of trans-dl-5-n-Propyl-7-hydroxymethyl-4,4a,5,6,7, 8,8a,9-octahydro-lH (and 2H)-pyrazolo[3,4-g]quinoline A mixture of trans-dl-5-n-propyl-7-ethoxycarbonyl15 4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g] quinoline dihydrochloride and the dihydrochloride salt of the IH tautomer (3.7 millimoles) (prepared in Example 3) was suspended in 200 ml. of THF. 1 g. of lithium aluminumhydride was added thereto in portions. The consequent reaction mixture was stirred at ambient temperature under a nitrogen atmosphere for about 16 hours, and was then cooled. Ethyl acetate and 10 percent aqueous sodium hydroxide were added thereto seriatium to react with any excess lithium aluminumhydride and to decompose organometallic compounds present. The reaction mixture so treated was then diluted with water and the aqueous mixture extracted several times with a chloroform-isopropanol solvent mixture. The organic layers were separated and combined. The combined layers were washed with saturated aqueous sodium chloride and then dried. Evaporation of the solvent yielded. a mixture of trans-dl-5-n-propyl-7-hydroxymethyl-4,4a,5,6,7,8, 8a,9-octahydro-2H-pyrazolo[3,4-g]quinoline and its IH tautomer The residue was dissolved in ethanol to which was added 0.2 •4839s -25ml. of 12N aqueous hydrochloric acid. Evaporation of the volatile constituents yielded a residue comprising trans-dl5-n-propyl-7-hydroxymethyl-4,4a,5,6,7,8,8a,9-octahydro-2H and lH-pyrazolo[3,4-g] quinoline dihydrochlorides. The residue was dissolved in a mixture of methanol and acetone to yield crystals melting at 27O-5°C. With decomposition; yield = 350 mg.
The above reaction was repeated with 1.55 g. of transdl-5-n-propyl-7-ethoxycarbonyl-4,4a,5,6,7,8,8a,9-octahydro-2Hpyrazolof3,4-g] quinoline in THF being reduced with an excess of lithium aluminumhydride. The product of the reaction, trans-dl-5-n-propyl-7-hydroxymethyl-4,4a,5,6,7,8,8a,9-octahydro-ΙΗ and 2H-pyrazolo[3,4-g] quinoline, was crystallized from a mixture of chloroform and ethanol to yield crystalline material melting at 167-9°C.
Analysis:Calculated; C, 67.43; H, 9.30; N, 16.85; FoundzC, 67.21; H, 9.13; N, 16.62.
Example 5 Alternate Preparation of l-n-Propyl-6-benzoyloxy-3,4,5,6,7,8hexahydro-2(lH)-quinolinone and l-n-Propyl-6-benzoyloxy-3,44a, 5,6,7-hexahydro-2(lH)-quinolinone A reaction mixture was prepared containing 4.4 g. of 4-benzoyloxycyclohexanone [prepared by the procedure of E.
R. H. Jones and F. Sondheimer, J. Chem. Soc.. 615 (1949)], 2.5 ml. of n-propylamine and 100 ml. toluene. The mixture was heated to reflux temperature for about 2 hours under a nitrogen atmosphere using a Dean-Stark water trap. The reaction mixture was then heated to refluxing temperature for an additional 2 hours in the presence of a molecular sieve to remove water. The reaction mixture was cooled and the solvent removed by evaporation in vacuo. 4 ml. of methyl acrylate and 100 ml. of dioxane were added to the residue and the resulting mixture - 26 was refluxed overnight under a nitrogen atmosphere. The reaction mixture was again cooled and the volatile constituents removed by evaporation in vacuo. Chromatography of an ethereal solution of the resulting residue over 200 g. of florisil using ether as an eluant yielded a mixture of 1n-propyl-6-benzoyloxy-3,4,5,6,7,8-hexahydro-2(IH)-quinolinone and 1-n-propy1-6-benzoyloxy-3,4,4a,5,6,7-hexahydro-2(IH)quinolinone: yield = 2.15 g.
Example 6 Preparation of trans-dl-5-n-Propyl-4,4a,5,6,7,8,8a,9-ootahydro-ΙΗ (and 2H)-pyrazolo[3,4-g] quinoline A reaction mixture was prepared from 6.3 g. of a mixture of trans-dl-5-cyano-4,4a,5,6,7,8,8a,9-octahydro-2Hpyrazolo[3,4-g] quinoline and its ΙΗ-tautomer (prepared by the procedure of Example 1 30 g. of zinc dust, 375 ml. of acetic acid and 75 ml. of water. The reaction mixture was heated to refluxing temperature under nitrogen for 16 hours after whioh time it was filtered and the filtrate poured over ice. The resulting aqueous mixture was made basic by the addition of 14N aqueous ammonium hydroxide and the alkaline layer extracted several times with a chloroform-isopropanol solvent mixture. The organic extracts were combined, the combined extracts washed with saturated aqueous sodium chloride and then dried. Evaporation of the solvent yielded a residue com25 prising trans-dl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinoline and its IH-tautomer formed in the above reaction. The residue was dissolved in 500 ml, of methanol to which was added 1.9 g. of sodium cyanoborohydride. Next 20 ml. of propionaldehyde were added and the resulting mixture stirred at ambient temperature under a nitrogen atmosphere for 28 hours. The reaction mixture was then poured into IN aqueous hydrochloric acid. The aqueous layer was extracted 18395 - 27 with ether and the ether extracts discarded. The aqueous layer was then made basic by the addition of an excess of 14N aqueous ammonium hydroxide and the resulting alkaline layer extracted several times with a chloroform-isopropanol solvent mixture. The organic extracts were combined and the combined extracts washed with saturated aqueous sodium chloride and then dried. Evaporation of the solvent yielded a residue comprising trans-dl-5-n-propyl-4,4a,5,6,7,8,8a,9octahydro-lH and 2H-pyrazolo[3,4-g]quinoline formed in the above reaction. Mass spectrum: M+ = 219.
The residue was dissolved in 100 ml. of boiling acetone to which were added 5 ml. of 12N aqueous hydrochloric acid in dropwise fashion. The mixture was cooled and the dihydrochlorides of trans-dl-5-n-propyl-4,4a,5,6,7,8,8a, 9-octahydro-lH and 2H-pyrazolo[3,4-g] quinoline thus formed separated by filtration; yield = 4.6 g.; m.p. = 25O-7°C.
Analysis:Calculated: C, 53.43; H, 7.93; N, 14.38; Cl, 24.26. Found; C, 53.15; fi, Cl, 24.33. Example 7 7.91; N, 14,47; Preparation of trans-dl-5-n-Propyl-4,4a,5,6,7,8,8a,9-octahydro-ΙΗ (and 2H)-pyrazolo[3,4-g] quinoline Using the procedure of Example 6, 1.2 g. of a mixture of trans-dl-5-cyano-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo~ [3,4-g]quinoline and its mixture of ΙΗ-tautomer were reacted with zinc dust and acetic acid to form a mixture of transdl-4,4a,5,6, 7,8,8a,9-octahydro-2H-pyrazolo[3,4-g] quinoline and its IH tautomer which was isolated as a residue. This residue dissolved in 50 ml. of DMF to which were added 1.7 g. of potassium carbonate. Next, 0.6 ml. of n-propyl iodide were added and the resulting mixture stirred at ambient temperature for about 4 hours under a nitrogen atmosphere. The reaction - 28 mixture was diluted with water and the resulting aqueous mixture extracted several times with ethyl acetate. The ethyl acetate extracts were combined and the combined extracts washed successively with water and saturated aqueous sodium chloride and were then dried. Evaporation of the ethyl acetate yielded a residue comprising trans-dl-5-n-propyl-44a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g] quinoline and its IH tautomer which was purified by chromatography over 30 g. of florisil using chloroform containing increasing amounts (2-10%) of methanol as the eluant. Fractions shown by TLC to contain trans-dl-5-n-propy1-4,4a,5,6,7,8,8a,9-octahydro-2H and lH-pyrazolo[3,4-g] quinoline were combined and the combined extracts evaporated to dryness to yield 0.28 g. of trans-dl5-n-propy1-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g] 15 quinoline and its IH tautomers. The residue was dissolved in ethanol to which was added 0.16 ml. of 12N aqueous hydrochloric acid, thus forming the dihydrochlorides of trans-dl-5n-propyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinoline and the IH tautomer. The reaction mixture was concentra20 ted in vacuo and the concentrate diluted with ether. A mixture of trans-dl-5-n-propyl-4,4a,5,6,7,8,8a,9-octahydro-lH and 2H-pyrazolo[3,4-g] quinoline dihydrochloride crystallized and was separated by filtration; m.p. = 276-8°C.
Example 8 Preparation of trans-dl-5-Methyl-4,4a,5,6,7,8,8a,9-octahydro1H (and 2H)-pyrazolo [3,4-g] quinoline 46.5 g. of the isomer mixture containing about 60 percent of 6-benzoyloxy-3,4,5,6,7,8-hexahydro-lH-quinoline-2one and 40% of the 3,4,4a,5,6,7-hexahydro isomer were dissolved in 400 ml. of tetrahydrofuran (THF). 80 ml. of methyl iodide were added and the resulting mixture cooled in an ice-water bath. 9.6 g. of sodium hydride (as a 50 percent suspension in mineral oil) were added in portions. After all of the sodium 4839S - 29 hydride suspension had been added, the cooling bath was removed and the reaction mixture stirred at ambient temperature under a nitrogen atmosphere for about 4 hours. The reaction mixture was then diluted with water and the aqueous mixture thoroughly extracted with chloroform. The chloroform extracts were combined and the combined extracts washed with saturated aqueous sodium chloride and then dried. Tha chloroform was removed by evaporation to dryness in vacuo leaving as a residue an orange oil weighing 47.3 g. Crystallization of the residue from an ether-hexane solvent mixture yielded crystals of l-methyl-6-benzoyloxy-3,4,5,6, 7,8-hexahydro-2(1H)-quinolinone and the corresponding 3,4,4a,5,6,7hexahydro isomer.
Analysis:Calculated: C, 71.56; H, 6.71; N, 4.91.
Found: C, 71.33; H, 6.90; N, 4.67.
A solution of 47.3 g. of a mixture of l-methyl-6benzoyloxy-3,4,5,6,7,8-hexahydro-2(lH)quinolinone and the corresponding 3,4,4a,5,6,7-hexahydro isomer as obtained above were dissolved in 800 ml. of THF and the solution cooled to about 0°C. 20 g. of lithium aluminumhydride were added thereto in portions and the resulting mixture refluxed for four hours under a nitrogen atmosphere. The reaction mixture was cooled and excess lithium aluminumhydride destroyed by the addition of ethyl acetate. 10% sodium hydroxide was then added and the mixture diluted with water to decompose any organometailies present. The aqueous mixture was extracted several times with a chloroform-isopropanol solvent mixture. The organic extracts were combined and the combined extracts washed with saturated aqueoue sodium chloride and then dried. Evaporation of the solvent yielded as a residue a mixture of the enamines-l-methyl-6-hydroxy-l,2,3,4,5,6,7,8-octahydroquinoline and l-methyl-6-hydroxy-l,2,3,4,4a,5,6,7-octahydro48395 - 30 quinoline— formed in the above reaction. (The lithium aluminumhydride reduction served to remove the benzoyl group at C-6 as a benzyl alcohol moiety, leaving a free hydroxyl in that position). The above residue, without further purifiea5 tion, was dissolved in about 300 ml. of ether and the ethereal solution saturated with gaseous hydrogen chloride, thus forming the hydrochloride salt of the enamine mixture.
The ether was removed by decantation and the residue dissolved in a mixture of 200 ml. of THF and 50 ml. of methanol. This solution was cooled in an ice-water bath. 12 g. of sodium cyanoborohydride were added with cooling and stirring. After all of the cyanoborohydride had been added, the reaction mixture was stirred for another 60 minutes and then poured over a mixture of ice and IN aqueous hydrochloric acid. The acidic aqueous solution was extracted with chloroform and the chloroform extract discarded. The solution was then made basic with 14N aqueous ammonium hydroxide. Trans-dl-l-methyl-6-hydroxydecahydroquinoline formed in the above reaction, being insoluble in the alkaline medium, separated and was extracted several times with a chloroform-isopropanol solvent mixture.
The combined extracts were washed with saturated aqueous sodium chloride and then dried. Evaporation of the solvent yielded 15 g. of trans-dl-l-methyl-6-hydroxydecahydroquinoline.
Fifteen grams of trans-dl-l-methyl-6-hydroxydeca25 hydroquinoline were dissolved in 250 ml.·· of 6N aqueous sulfuric acid. The solution was cooled in an ice-water bath.
A solution of 9 g. of chromium trioxide in 60 ml. of 6N aqueous sulfuric acid were added thereto with stirring in dropwise fashion over a 10-minute period. The cooling bath was removed and the reaction mixture stirred for an additional 60 minutes at ambient temperature. The excess oxidizing agent was decomposed by adding isopropanol to the reaction mixture. The reaction mixture was next poured over ice and the acidic 8 3 9 S - 31 aqueous solution made basic with 14n aqueous anrnonium hydroxide. trans-dl-l-Methyl-6-oxodecahydroquinoline thus farmed, being insoluble in the alkaline layer, separated and was extracted several times with a mixture of chloroform and isoprcpanol. The extracts were combined and the combined extracts washed with saturated aqueous sodium chloride and then dried. Evaporation of the solvent in vacuo yielded trans-dl-l-methyl-6-oxodecaiydroquinoline boiling in the range 105116°C. at 6 torr; yield = 7.7 g. (45%).
A reaction mixture was prepared frcm 7.7 g. of trans-dl-1methyl-6-oxodecahydroquinoline, 36 g. of the dimethyl acetal of dimethylformamide and 250 ml. of benzene. Benzene was removed by distillation at atmospheric pressure under nitrogen until about 1/2 the original volume remained (1.25 hours). Sufficient benzene was then added to make up the volume to the original voltme and the process was repeated (four times). All of the benzene was finally removed hy evaporation in vacuo and the resulting residue dissolved in 100 g. of dimethylformamide dimethylacetal. This solution was heated to refluxing tenperature under nitrogen for 20 hours. The reaction mixture was then evaporated in vacuo and a chloroform solution of the residue chromatographed over 150 g. of florisil using as the eluant, methylene dichloride containing increasing amounts (1-5%) of methanol. Fractions containing similar substances as shown by TLC were combined, lhe third substance to be eluted was a yellow solid (wt = 3 g.) The solid was heated with 100 ml. of ether and the resulting solution filtered. Concentration of the filtrate to about 50 ml. yielded 590 ng. of crystals of trans-dl-1mthyl-6-CKO-7~dimsthylaminanettylenedecabydroquinoline melting at 107-109°C.
Analysis: Calculated: C, 70.23; H, 9.97: N, 12.60.
Bound: C, 70.17; H, 9.74; N, 12.87.
A solution was prepared by dissolving 175 mg. of transdl-l-inethyl-6-oxD-7-dimethylaminanethylenedecahydroquinoline in 10 ml. of methanol. 0.05 ml. of hydrazine hyd48395 - 32 rate were added and the resulting reaction mixture stirred at room temperature under a nitrogen atmosphere for 4.5 days. The volatile constituents were removed by evaporation. A chloroform solution of the residue was chromatographed over g. of florisil using chloroform containing increasing amounts (2-15%) of methanol as the eluant. Fractions shown by TLC to contain a substance moving close to the origin and different than starting material were combined and the solvent, removed from the combined fractions by evaporation, trans-dl10 5-methyl-4,4a,5,6,7,8,8a,9-octahydro-lH- (and 2H)-pyrazolo[3,4-g]quinoline free base gave a molecular ion (M+) at 191 by mass spectroscopy.
The resulting residue was dissolved in ethanol and 2 ml. of IN hydrochloric acid were added. The acidic solution was evaporated to dryness. Crystallization of the residue from ethanol yielded a tautomeric mixture containing trans-dl-5methyl-4,4a,5,6,7,8,8a,9-octahydro-lH (and 2H)-pyrazolo[3,4-g]quinoline dihydrochlorides melting at 268-7O°C. with decomposition; yield = 140 mg.
Analysis:Calculated: C, 50.01; H, 7.25; N, 15.90; C. 26.84.
Found: C, 49.82; H, 7.08; H, 15.66; Cl, 26.80.

Claims (6)

1. Compounds of the general formulae Ic Id wherein 5 R is H, CN, C-]. -C 3 a ^Y^· or benzyl; R 1 is H, -COOH, -COOiCj-C^alkyl, or CH 2 X wherein X is Cl, Br, I, OR, OSO 2 ~ (.C -C )alkyl, OSO 2 tolyl, or 0S0 2 phenyl; with the proviso that when R is C^-C 3 alkyl, then R 1 10 can not be H; and the salts thereof.
2. As tautomers trans-dl-5-n-Propyl-7-ethoxycarbonyl4,4a,5,6,7,8,8a,9-octahydro-lH (and 2H)-pyrazolo[
3. ,4-g]quinoline. 15 3, As tautomers trans-dl-5-n-Propyl-7-hydroxymethyl4,4a, 5,6,7,8,8a, 9-octahydro-lH (and 2H) -pyrazolo[3,4-g] guinoline.
4. As tautomers trans-dl-
5. -Cyano-4,4a,5,6,7,8,8a,9octahydro-ΙΗ (and 2H)-pyrazolo[3,4-g]quinoline. 20 5. As tautomers trans-dl-4,4a,5,6,7 ; 8,8a,9-octahydro1H (and 2H)-pyrazolo[3,4-g]quinoline.
6. A compound of claim 1 as herein described with reference to any one of the Examples.
IE2794/83A 1979-01-22 1979-08-08 Octahydro pyrazolo(3,4-g)quinolines IE48395B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US506179A 1979-01-22 1979-01-22
US06/031,641 US4198415A (en) 1979-01-22 1979-04-19 Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
IE1209/79A IE48394B1 (en) 1979-01-22 1979-08-08 Octahydro pyrazolo(3,4-g)quinolines

Publications (1)

Publication Number Publication Date
IE48395B1 true IE48395B1 (en) 1985-01-09

Family

ID=27270361

Family Applications (2)

Application Number Title Priority Date Filing Date
IE2795/83A IE48396B1 (en) 1979-01-22 1979-08-08 6(oxo-or hydroxy-)decahydroquinolines
IE2794/83A IE48395B1 (en) 1979-01-22 1979-08-08 Octahydro pyrazolo(3,4-g)quinolines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IE2795/83A IE48396B1 (en) 1979-01-22 1979-08-08 6(oxo-or hydroxy-)decahydroquinolines

Country Status (1)

Country Link
IE (2) IE48396B1 (en)

Also Published As

Publication number Publication date
IE48396B1 (en) 1985-01-09

Similar Documents

Publication Publication Date Title
EP0013787B1 (en) Octahydro pyrazolo (3,4-g)quinolines, process for their preparation and pharmaceutical compositions containing them
US4235909A (en) Octahydro-2H-pyrrolo[3,4-g]quinolines
Wentland et al. Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships
US4230861A (en) 1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids
US4826986A (en) 6-Oxo-trans-octa- and decahydroquinolines
CA1131227A (en) Octahydro-2h-pyrrolo (3,4,-g) quinolines
IE48395B1 (en) Octahydro pyrazolo(3,4-g)quinolines
US4367231A (en) Method of using octahydro pyrazolo[3,4-g]quinolines
US4471121A (en) Method of resolving trans-d alpha-1-n-propyl-6-oxodecahydroquinoline and di-p-toluoyltartaric acid salts thereof
US4201862A (en) 2-Azaergolines and 2-aza-8(or 9)-ergolenes
CA1133487A (en) Octahydro pyrazolo (3,4-g) quinolines
CA1145750A (en) Octahydro-2h-pyrrolo (3,4,-g) quinolines
CA1136629A (en) Octahydro pyrazolo (3,4,-g) quinolines
US4311844A (en) Octahydro-2H-pyrrolo[3,4,-g]quinolines
CA1136141A (en) Octahydro pyrazolo (3,4,-g) quinolines
US5134143A (en) BCD tricyclic ergoline part-structure analogues
EP0142920A2 (en) 6-Oxodecahydroquinolines and process for their preparation
US4282362A (en) Octahydro-2H-pyrrolo[3,4-g]quinolines
KR830000586B1 (en) Method for preparing octahydro-2H-pyrrolo [3, 4-g] quinoline
US4977160A (en) BCD tricyclic ergoline part-structure analogues
CA1136144A (en) Octahydro pyrazolo (3,4,-g) quinolines
HU190390B (en) Process for producing octahydro-pyrazolo-square bracket-3,4-g-square bracket closed-quinolines
KR830000326B1 (en) Method for preparing octahydropyrazolo [3,4-g] quinoline
FI68052B (en) TRANSMISSION OF THERAPEUTIC ANALYTICAL PRODUCTS TRANS-4,4A, 5,6,7,8,8A, 9-OCTAHYDRO-1H (OCH 2H) -PYRAZOLO- (3,4-G) QUINOLINER
NO174670B (en) Analogous Procedures for Preparation of Therapeutically Active 1H-Pyrido- (4,3-b) Indol-1-One Derivatives